Pressure BioSciences Inc (OTCPK:PBIO)

$ 0.225 0.0122 (5.73%) Market Cap: 5.79 Mil Enterprise Value: 26.99 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 22/100

Q2 2023 Pressure Biosciences Inc Earnings Call Transcript
Aug 22, 2023

$0.29815 (-9.92%)

Earnings
Q1 2023 Pressure Biosciences Inc Earnings Call Transcript
May 16, 2023

$0.9

Earnings
Q4 2022 Pressure Biosciences Inc Earnings Call Transcript
Apr 18, 2023

$1 (-8.05%)

Earnings
Pressure Biosciences Inc at Emerging Growth Virtual Conference Transcript
Mar 22, 2023
Pressure Biosciences Inc at Issuer Direct Planet MicroCap Showcase (Virtual) Transcript
Dec 07, 2022
Q3 2022 Pressure Biosciences Inc Earnings Call Transcript
Nov 22, 2022

$1.19 (-6.30%)

Earnings
Pressure Biosciences Inc at LD Micro Main Event Transcript
Oct 26, 2022
Pressure Biosciences Inc at Emerging Growth Conference Transcript
Sep 28, 2022
Q2 2022 Pressure Biosciences Inc Earnings Call Transcript
Aug 18, 2022

$1.74 (+3.57%)

Earnings
Pressure Biosciences Inc at Emerging Growth Conference Transcript
Jul 06, 2022
Pressure Biosciences Inc Revolutionizing the Development of Plant Based Products Transcript
Jun 30, 2022
Q1 2022 Pressure Biosciences Inc Earnings Call Transcript
May 19, 2022

$1.73 (+1.76%)

Earnings
Q4 2021 Pressure Biosciences Inc Earnings Call Transcript
Apr 05, 2022

$2 (-2.91%)

Earnings
Pressure Biosciences Inc At Innovations and Advancements in the CBD Market Webinar Transcript
Jan 20, 2022
Pressure Biosciences Inc At Benzinga ALL ACCESS Investor Event Transcript
Nov 04, 2021
Pressure Biosciences Inc at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
Sep 30, 2021
Pressure Biosciences Inc at Emerging Growth Conference Transcript
Sep 29, 2021
Pressure Biosciences Inc at Emerging Growth Conference Transcript
Aug 18, 2021
Q3 2020 Pressure Biosciences Inc Earnings Call Transcript
Nov 17, 2020

$1.61 (-2.42%)

Earnings

Q4 2022 Pressure Biosciences Inc Earnings Call Transcript

Apr 18, 2023 / 08:30PM GMT

Release Date Price: $1 (-8.05%)

Transcript 10-K

Operator

Greetings. Welcome to the Pressure BioSciences Q4 and fiscal year 2022 financial results and business update call. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, Richard Schumacher, President and CEO. You may begin.

Richard Schumacher

Pressure BioSciences, Inc. - President, CEO

Thank you, John, and welcome, everybody, to our fourth quarter and fiscal year 2022 review and business update. Before I begin with the actual call, I need to read a cautionary statement. The following remarks may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results performance or achievements expressed or implied by such forward-looking statements.

Such factors include among others those detailed from time to time

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.